Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Barrecheguren Fernandez (Barcelona, Spain), M. Pons (Barcelona, Spain), M. Torres (Vigo, Spain), R. Tubio (Vigo, Spain), A. Núñez (Barcelona, Spain), I. Martín-Granizo (Vigo, Spain), M. Figueira-Álvarez (Vigo, Spain), E. Rodríguez (Barcelona, Spain), C. Esquinas (Barcelona, Spain), J. Genesca (Barcelona, Spain), M. Miravitlles (Barcelona, Spain). Screening of chronic liver disease by transient elastography in patients with lung disease associated with alpha-1 antitrypsin deficiency.. 569

Member's Comments

No comment yet.

Related content which might interest you: Screening for alpha-1 antitrypsin deficiency in Polish lung or liver disease patients Source: Annual Congress 2011 - Lung development and neoplasia Year: 2011 Screening for α1-Pi deficiency in patients with lung diseases Source: Eur Respir J 2002; 20: 319-324 Year: 2002 Comparison of outcomes in augmentation naïve and augmented patients with alpha-1 antitrypsin deficiency related lung disease. Source: International Congress 2019 – COPD clinical studies: bronchodilators, corticosteroids and more Year: 2019 Monitoring disease progression in severe Alpha1 antitrypsin deficiency Source: Virtual Congress 2020 – Clinical and basic pharmacology for COPD Year: 2020 The undiagnosed disease burden associated with alpha-1 antitrypsin deficiency genotypes Source: Eur Respir J, 56 (6) 2001441; 10.1183/13993003.01441-2020 Year: 2020 Laboratory testing of individuals with severe α1-antitrypsin deficiency in three European centres Source: Eur Respir J 2010; 35: 960-968 Year: 2010 Rate of progression of lung function impairment in α1-antitrypsin deficiency Source: Eur Respir J 2009; 33: 1338-1344 Year: 2009 Mechanisms of liver disease in AATD Source: Eur Respir Monogr 2019; 85: 93-104 Year: 2019 Study of lung functions in patients of chronic liver disease. Source: International Congress 2017 – Miscellaneous clinical problems Year: 2017 Degree of knowledge among physicians about the diagnosis and treatment of alpha-1 antitrypsin deficiency Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015 Alpha-1-antitrypsin deficiency Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=139 Year: 2005 Screening for cystic fibrosis among high risk group patients with chronic lung disease Source: Eur Respir J 2002; 20: Suppl. 38, 340s Year: 2002 Treatment of lung disease in patients with AATD Source: Eur Respir Monogr 2019; 85: 78-92 Year: 2019 Smoke exposure as a determinant of autoantibody titre in alpha 1-antitrypsin deficiency and COPD Source: Eur Respir J 2011; 37: 32-38 Year: 2011 Frequency and features of formation of chronic kidney disease (CKD) in patients with chronic obstructive pulmonary disease. Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases Year: 2019 Impact of COVID-19 on patients with chronic lung disease Source: Virtual Congress 2021 – COVID - 19 epidemiology Year: 2021 Specific airway resistance as a marker of early disease in alpha-1 antitrypsin deficiency Source: International Congress 2015 – Lung function: exploring the boundaries of the respiratory system Year: 2015 Iron deficiency as a novel biomarker of functional impairment in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2011 - Physiological basis of respiratory disease Year: 2011 Lung function in relation to emphysema development in alpha-1 antitrypsin deficiency Source: International Congress 2019 – Insights into physiological diagnostic services Year: 2019 Exercise intolerance and lung emphysema in alpha-1 antitrypsin deficiency (AATD) Source: Annual Congress 2010 - Exercise in COPD Year: 2010